Vikelis M, Kourlaba G, Barba L, Bilias K, Barbalia E, Solakidi A
Front Neurol. 2025; 16:1558014.
PMID: 40066304
PMC: 11892325.
DOI: 10.3389/fneur.2025.1558014.
Zhu Z, Tang Y, Li L, Ni H, Liu M, Chen Z
J Headache Pain. 2025; 26(1):48.
PMID: 40065213
PMC: 11892237.
DOI: 10.1186/s10194-025-01984-7.
Vigano A, Petolicchio B, Toscano M, Ruggero S, Di Giambattista R, Puma M
Neurol Sci. 2025; .
PMID: 40048115
DOI: 10.1007/s10072-025-08075-0.
Kourlaba G, Vikelis M, Karapanayiotides T, Solakidi A, Trafalis D, Lioliou K
Front Neurol. 2025; 16:1556808.
PMID: 40040919
PMC: 11878100.
DOI: 10.3389/fneur.2025.1556808.
Huang Y, Li H, Yu Q, Pan Y
Front Neurosci. 2025; 19:1500189.
PMID: 40027467
PMC: 11868061.
DOI: 10.3389/fnins.2025.1500189.
Up-regulation of MAPK14-related lncRNAs in the circulation of migraineurs.
Talemi F, Hussen B, Keshmir F, Movafagh A, Sarabi P, Rahmanian M
Sci Rep. 2025; 15(1):7250.
PMID: 40021777
PMC: 11871286.
DOI: 10.1038/s41598-025-91943-8.
An Assessment of the Dietary Habits of Individuals with Migraine Living in Spain: An Exploratory Observational Cross-Sectional Pilot Study.
Esteves-Mesquita V, Fernandez-Cardero A, Sarria B, Martin-Cabrejas I
Nutrients. 2025; 17(4).
PMID: 40005014
PMC: 11857930.
DOI: 10.3390/nu17040686.
Health Technology Assessment: Evaluation of 8 CGRP-Targeted Therapy Drugs for the Treatment of Migraine.
Li M, Huang S, Li J, Hu X, Chen J
Drug Des Devel Ther. 2025; 19:1231-1247.
PMID: 39991088
PMC: 11847418.
DOI: 10.2147/DDDT.S499848.
Migraine and stroke: correlation, coexistence, dependence - a modern perspective.
Boronczyk M, Zdunska A, Wegrzynek-Gallina J, Grodzka O, Lasek-Bal A, Domitrz I
J Headache Pain. 2025; 26(1):39.
PMID: 39979846
PMC: 11844069.
DOI: 10.1186/s10194-025-01973-w.
Cortical astrocyte activation triggers meningeal nociception and migraine-like pain.
Bree D, Zhao J, Stratton J, Levy D
bioRxiv. 2025; .
PMID: 39975142
PMC: 11839082.
DOI: 10.1101/2025.02.08.637109.
Anatomical and physiological contributions of nasal turbinate vessels and lymphatics to the pathogenesis of nasal congestion in recurrent headaches: a pilot study.
Chmielecki J, Vemula A, Schwartz J, Gelfond J, Phillips W
Front Pain Res (Lausanne). 2025; 6:1521500.
PMID: 39974311
PMC: 11835829.
DOI: 10.3389/fpain.2025.1521500.
Uncovering longitudinal changes in the brain functional connectome along the migraine cycle: a multilevel clinical connectome fingerprinting framework.
Esteves I, Fouto A, Ruiz-Tagle A, Caetano G, Nunes R, da Silva N
J Headache Pain. 2025; 26(1):29.
PMID: 39930372
PMC: 11812190.
DOI: 10.1186/s10194-025-01969-6.
Global trends in migraine and anxiety over the past 10 years: a bibliometric analysis.
Huang B, Chen W, Peng C, Wang Y, Shen X, Zhang Q
Front Neurol. 2025; 15:1448990.
PMID: 39917435
PMC: 11799673.
DOI: 10.3389/fneur.2024.1448990.
Investigating risk factors for migraine in Syrian women: a cross-sectional case-control study.
Martini N, Hawa T, Almouallem M, Hanna M, Almasri I, Hamzeh G
Sci Rep. 2025; 15(1):4148.
PMID: 39900976
PMC: 11791034.
DOI: 10.1038/s41598-025-87487-6.
Understanding Deep Endometriosis: From Molecular to Neuropsychiatry Dimension.
Pszczolowska M, Walczak K, Kolodziejczyk W, Kozlowska M, Kozlowski G, Gachowska M
Int J Mol Sci. 2025; 26(2).
PMID: 39859551
PMC: 11765589.
DOI: 10.3390/ijms26020839.
The epidemiology and unmet need of migraine in five european countries: results from the national health and wellness survey.
Coppola G, Brown J, Mercadante A, Drakeley S, Sternbach N, Jenkins A
BMC Public Health. 2025; 25(1):254.
PMID: 39838307
PMC: 11753071.
DOI: 10.1186/s12889-024-21244-8.
Machine learning-driven identification of critical gene programs and key transcription factors in migraine.
Zhang L, Li Y, Xu Y, Wang W, Guo G
J Headache Pain. 2025; 26(1):14.
PMID: 39833696
PMC: 11745026.
DOI: 10.1186/s10194-025-01950-3.
Efficacy of prophylactic sodium valproate in pediatric migraines: a systematic review of randomized clinical studies.
Askar G, Askar O, Altuhafy M, Nagi R, Khan J
Transl Pediatr. 2025; 13(12):2254-2266.
PMID: 39823012
PMC: 11732630.
DOI: 10.21037/tp-24-279.
Serial systemic immune inflammation indices: markers of acute migraine events or indicators of persistent inflammatory status?.
Wijeratne T, Murphy M, Wijeratne C, Martelletti P, Karimi L, Apostolopoulos V
J Headache Pain. 2025; 26(1):7.
PMID: 39794705
PMC: 11721065.
DOI: 10.1186/s10194-024-01929-6.
US Real-World Effectiveness, Tolerability, and Healthcare Resource Utilization After Addition of Fremanezumab for Preventive Treatment in Patients Using Gepants for Acute Treatment of Migraine: Results From a Retrospective Chart Review.
Eugeni P, Rooney M, Saikali N, Niu Z, Driessen M, Krasenbaum L
Adv Ther. 2025; 42(2):1207-1221.
PMID: 39775579
PMC: 11787160.
DOI: 10.1007/s12325-024-03063-w.